logo

Fennec Pharmaceuticals Inc (FENC)



Trade FENC now with
  Date
  Headline
10/17/2022 8:07:22 AM Fennec Pharma Announces Commercial Availability Of PEDMARK In The United States
9/21/2022 8:01:42 AM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $11 Price Target
9/21/2022 7:31:45 AM Fennec Pharma Announces FDA Approval Of PEDMARK
4/27/2022 6:46:07 AM Fennec Pharma Announces FDA Acceptance For Filing Of NDA Resubmission For PEDMARK
3/24/2022 4:24:27 PM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $10 Price Target
3/24/2022 6:17:04 AM Fennec Pharma Resubmits NDA For Pedmark
2/28/2022 4:56:02 PM Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) FY22 Estimate To -0.54 From -0.51
2/28/2022 4:55:47 PM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 22 Estimate To -0.14 From -0.13
2/28/2022 4:55:37 PM Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q1 22 Estimate To -0.14 From -0.12
2/28/2022 4:55:10 PM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $10 Up From $9 Price Target
1/31/2022 6:19:15 AM Fennec Pharma's Chief Commercial Officer Shubh Goel To Depart In Late February
11/30/2021 6:06:52 AM Fennec Pharma Receives CRL From FDA For PEDMARK NDA Again
11/29/2021 6:24:08 AM Fennec Pharma Expects To Receive CRL From FDA For PEDMARK NDA